Proton pump inhibitors remain a frontline treatment for gastro-oesophageal reflux disease, new guidelines have confirmed. The latest update to the Asia-Pacific consensus on the management of GERD – the first since 2008 – has been published in the British Medical Journal’s publication Gut. Co-author, Professor Gerald Holtmann, Director of Gastroenterology and Hepatology, Princess Alexandra Hospital ...
PPIs remain frontline treatment for GERD: Guidelines
By Amanda Sheppeard
17 Jun 2016